Local Delivery and Controlled Release Drugs Systems: A New Approach for the Clinical Treatment of Periodontitis Therapy
Pharmaceutics · 21.04.2023 · 15 (4) · 1312
DOI: 10.3390/pharmaceutics15041312 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 21.04.2023. Verfasst von Mariacristina Amato und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery and Surgical-Medical Specialties, School of Dentistry, University of Catania, 95124 Catania, Italy. Die Arbeit wurde bisher 112-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Periodontitis is an inflammatory disease of the gums characterized by the degeneration of periodontal ligaments, the formation of periodontal pockets, and the resorption of the alveolar bone, which results in the destruction of the teeth’s supporting structure. Periodontitis is caused by the growth of diverse microflora (particularly anaerobes) in the pockets, releasing toxins and enzymes and stimulating the immune system. Various approaches, both local and systemic, have been used to treat periodontitis effectively. Successful treatment depends on reducing bacterial biofilm, bleeding on probing (BOP), and reducing or eliminating pockets. Currently, the use of local drug delivery systems (LDDSs) as an adjunctive therapy to scaling and root planing (SRP) in periodontitis is a promising strategy, resulting in greater efficacy and fewer adverse effects by controlling drug release. Selecting an appropriate bioactive agent and route of administration is the cornerstone of a successful periodontitis treatment plan. In this context, this review focuses on applications of LDDSs with varying properties in treating periodontitis with or without systemic diseases to identify current challenges and future research directions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery and Surgical-Medical Specialties, School of Dentistry, University of Catania, 95124 Catania, Italy.
- UOC Maxillo-Facial Surgery and Dentistry, Department of Biomedical, Surgical and Dental Sciences, School of Dentistry, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, University of Milan, 20100 Milan, Italy.
- Department of Head and Neck, Division of Oral Surgery and Implantology, Catholic University of the Sacred Heart, Fondazione Policlinico Gemelli IRCCS, 00168 Rome, Italy.
ORCID-Profile: Mariacristina Amato, Simona Santonocito, Alessandro Polizzi, Vincenzo Ronsivalle, Cristina Grippaudo, Gaetano Isola
Zitieren
APA
Amato, M., Santonocito, S., Polizzi, A., Tartaglia, G. M., Ronsivalle, V., Viglianisi, G., Grippaudo, C., & Isola, G. (2023). Local Delivery and Controlled Release Drugs Systems: A New Approach for the Clinical Treatment of Periodontitis Therapy. Pharmaceutics, 15(4), 1312. https://doi.org/10.3390/pharmaceutics15041312
Vancouver
Amato M, Santonocito S, Polizzi A, Tartaglia GM, Ronsivalle V, Viglianisi G, et al. Local Delivery and Controlled Release Drugs Systems: A New Approach for the Clinical Treatment of Periodontitis Therapy. Pharmaceutics. 2023;15(4):1312. doi:10.3390/pharmaceutics15041312
BibTeX
@article{Amato2023,
author = {Amato, Mariacristina and Santonocito, Simona and Polizzi, Alessandro and Tartaglia, Gianluca Martino and Ronsivalle, Vincenzo and Viglianisi, Gaia and Grippaudo, Cristina and Isola, Gaetano},
title = {Local Delivery and Controlled Release Drugs Systems: A New Approach for the Clinical Treatment of Periodontitis Therapy},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {4},
pages = {1312},
doi = {10.3390/pharmaceutics15041312}
}
EUVIMED